Cube Iovir Nasal Spray 20ml - against viral infections
Cube Iovir Nasal Spray – Antiviral Adjunctive Therapy
For Viral Infections of the Upper Respiratory Tract
The clinically proven iovir® range of antiviral medical devices offers a simple, natural, safe, and easy way to prevent and provide adjunctive treatment for viral infections of the upper respiratory tract.
iovir® is designed and developed based on the patented Carragelose® technology platform. This platform is used to develop treatments that target over 200 different respiratory viral strains responsible for the common cold and flu-like illnesses. iovir® (nasal spray) contains the natural functional ingredient Carragelose® (kappa-carrageenan), derived from red seaweed.
It possesses the unique ability to create a protective barrier against common cold viruses; it traps upper respiratory viruses—broadly and non-selectively—preventing them from attaching to the mucous membrane, thereby inhibiting their replication and spread.
It also forms a moisturizing, protective film. Due to the action of Carragelose®, this film remains on the nasal mucosa for a longer period, serving as a physical barrier against external influences. At the same time, this moisture-retaining film supports the body’s natural defense mechanisms against common cold viruses.
The only one suitable from 1 year of age
Clinically proven safety and efficacy in children from 1 year of age and adults
Multi-action (protects, treats, relieves, moisturizes)
Features a unique mechanical action. Not absorbed by the body; does not cause addiction
No risk of overdose
No restrictions on duration of use
Contains no pharmaceutical substances or preservatives
Suitable for pregnant and breastfeeding women
Suitable for diabetics
Suitable for vegans
Special filter – remains sterile throughout its entire period of use
USE
PROTECTION
iovir® creates a natural, protective, moisture-retaining film on the mucous membrane of the nasal cavity. This film acts against external factors by preventing viruses from attaching to cell membrane receptors, thereby naturally supporting the body’s defenses.
TREATMENT
iovir® has the ability to trap viruses by forming a "cocoon" around them. In this way, the interaction between viruses and cells is prevented, while the process of their replication and spread throughout the body is inhibited.
RELIEF / HYDRATION
The protective, natural moisture film provided by iovir®, combined with the containment of the factor that triggers inflammation of the mucous membrane, offers both immediate and prolonged relief from symptoms such as runny nose, sore throat, hoarseness, and a sensation of dryness. DOSAGE
1 spray per nostril at least 3 times a day, or according to individual needs
Large-scale clinical studies in children and adults have demonstrated that it:
Significantly reduces viral load (in clinical cases involving the presence of more than one distinct viral strain)
Reduces the total duration of the viral infection
Reduces the recurrence (relapse) of the viral infection
CHARACTERISTICS
Can reduce the duration of flu-like illness and the intensity of common cold symptoms
Can reduce the occurrence of new infections and the recurrence of symptoms associated with the common cold
Indicated for the prevention and supportive management of viral infections of the upper respiratory tract
Can also be used for the prophylactic and prolonged moisturizing of the nasal mucosa, aimed at preventing and supporting the management of issues related to a dry or irritated nasal mucosa
Protected by patents
Free from sugar, lactose, gluten, and ingredients of animal origin
MEDICAL DEVICE Class IIa Sterile
| Manufacturer | Cube Pharmaceuticals |
|---|---|
| Pieces | 1 |
| Site Code | 4198 |
| ean13 | 5213005010034 |
| Content (ml) | 20 |














